Teitur Trophics joins the BII Creation House program

The pharma company Teitur Trophics that targets neurodegenerative diseases has joined the BII Creation House program.

As part of the Creation House program, Teitur Trophics will have access to a global network of life science entrepreneurs and investors, labs and office space, business development and DKK 10M in funding during the coming 18 months.

For more information:

BII funds therapeutics start-up from Aarhus University